Posted by Clinical Lab Products | Jan 10, 2004 | Cancer, Miscellaneous |
ASH Meeting Addresses Developments in Treating Blood Disorders Approximately 20,000 physicians and scientists from around the world gathered for the 45th Annual Meeting of the American Society of Hematology (ASH), December 6–9, 2003, at the S
Read MorePosted by Clinical Lab Products | Dec 11, 2003 | Miscellaneous, Osteoporosis |
AusAm Biotechnologies Receives Approval to Market Test for Kidney Disease AusAm Biotechnologies Inc has received the CE Mark of approval for the Microalbumin Plus™, which aids in the detection of microalbuminari
Read MorePosted by Clinical Lab Products | Dec 4, 2003 | Miscellaneous |
By Nicholas Borgert Bio-Rad Laboratories has expanded its TOX/See™ Rapid Urine Drug Screen platform with new capabilities to detect tricyclic antidepressants (TCA) and Ecstasy (MDMA). The new tests have been added to a TOX/See test menu tha
Read MorePosted by Clinical Lab Products | Nov 1, 2003 | Infectious Diseases |
By Nicholas Borgert Public awareness about infectious diseases continues to be an issue while diagnostics providers move forward with tests aimed at new risks and a few well-established ones. Recent months have brought introduction of a rapid HIV
Read MorePosted by Clinical Lab Products | Oct 10, 2003 | Miscellaneous |
Wampole Laboratories Signs Agreement to Acquire Exclusive US Distribution Rights for HIV Test Wampole Laboratories, a division of Inverness Medical Inc, has entered into an agreement with Efoora Inc of Buffalo Grove, Ill, for exclusive US distribu
Read More